Physicians sort out pros and cons of several new IOLs on the market
Nov 12, 2021 · Multifocal IOLs The 2 newest multifocal IOLs—AcrySof IQ PanOptix (Alcon) and Tecnis Synergy (Johnson + Johnson Vision)—almost guarantee a broader range of vision than EDoF IOLs but not the avoidance of photic phenomena, Sood said. The PanOptix is a trifocal lens with negative spherical aberration on its anterior surface that has diffractive ...
Ophthalmology Times - Ophthalmology news, articles, and events
Oct 5, 2024 · This Week in Ophthalmology: Week of September 29, 2024. By David Hutton. October 5th 2024. This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website. Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Alcon reveals final data from Vivity Registry Study which …
Sep 13, 2023 · Alcon has announced final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
Aug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
News - Ophthalmology Times
Orasis Pharmaceuticals completes $78 million financing to support commercial launch of Qlosi. October 8th 2024. According to the company, a $68 million Series D financing is co-led by Arboretum Ventures and Johnson & Johnson Innovation – JJDC Inc. It also has secured $15 million in structured capital from Catalio Capital Management, with $10 ...
Breaking down the dorzolamide shortage - Ophthalmology Times
Aug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a positive ...
Study: Supplements slow disease progression during late stage of …
Jul 21, 2024 · A team of researchers at the National Institutes of Health (NIH), in a new analysis of data, have found that taking a daily supplement containing antioxidant vitamins and minerals can slow the progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision.
nAMD patients successfully switch from aflibercept to biosimilar ...
Sep 13, 2024 · The study, 1 published in Clinical Ophthalmology, was a multicenter observational study on patients over the age of 50 with nAMD. Patients were shifted from intravitreal aflibercept to biosimilar ranibizumab due to financial constraints. In total, 29 eyes were analyzed, 12 male and 17 female, with a mean age of 72.55 ±6.43 years.
Managing Dry Eye for Pre-Surgery Patients - Ophthalmology Times
Oct 30, 2023 · Managing Dry Eye for Pre-Surgery Patients. Author (s): Marguerite B. McDonald, MD, FACS Peter McDonnell, MD. SHOW ALL. Experts discuss how dry eye disease can impact the preparation and post-operative care of cataract or refractory surgery, highlighting key approaches to successfully managing these patients. EP: 1.
Researchers monitor eye microcirculation using multiwavelength …
Jul 16, 2024 · Scientists from the International Centre from Translational Eye Research used multiwavelength laser Doppler holography to assess blood flow in various layers of the human retina in vivo, which may impact the diagnosis of circulatory disorders.